UOC
NERV icon

UBS O'Connor’s Minerva Neurosciences NERV Stock Holding History

UBS O'Connor’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-107,256
Closed -$238K – 418
2024
Q4 		$238K Hold
107,256
– – 0.01% 320
2024
Q3 		$286K Buy
107,256
+7,400
+7% +$21.5K 0.01% 371
2024
Q2 		$319K Buy
99,856
+212
+0.2% +$574 0.01% 393
2024
Q1 		$257K Buy
99,644
+35,000
+54% +$215K 0.01% 381
2023
Q4 		$398K Sell
64,644
-5,356
-8% -$30.6K 0.01% 371
2023
Q3 		$483K Buy
+70,000
New +$627K 0.01% 404

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS O'Connor's NERV Position: Q1 2025 in Review

UBS O'Connor sold out of Minerva Neurosciences (NERV) in Q1 2025, closing a stake of 107,256 shares — an estimated $238K sold.

UBS O'Connor first reported a position in NERV in Q3 2023 and held it in 6 quarters. The position peaked at $483K in Q3 2023. 22 funds tracked by Wall St. Rank hold NERV as of Q1 2025.

  • UBS O'Connor reported no remaining Minerva Neurosciences position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 107,256 Minerva Neurosciences shares in Q1 2025, an estimated $238K.
  • UBS O'Connor first reported a position in Minerva Neurosciences in Q3 2023 and held it in 6 quarters.
  • UBS O'Connor's Minerva Neurosciences position peaked at $483K in Q3 2023.
  • 22 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.